Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors

The purpose of this international study is to try to predict which patients are more likely to have side effects from radiotherapy

News

REQUITE on Facebook

Dirk de Ruysscher is one of the speakers today in an educational session at the 8th European Lung Cancer Congress (ELCC).

The 8th edition of the European Lung Cancer Congress (ELCC) will take place from 11-14 April, in Geneva, Switzerland. The European Lung Cancer Congress is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, all working towards a shared goal: to advance science, disseminate education and improve the practice of lung cancer specialists worldwide.

Abstract accepted as oral presentation at the DEGRO conference 2018!

In 2016, Irmgard Helmbold, study physician,  presented some preliminary findings on hypofractionation and acute toxicity among prostate cancer patients at the conference of the German Society for Radiooncology (DEGRO) to introduce the REQUITE study more widely. She and the co-authors like to present updated results at this year’s DEGRO conference, so we are very pleased that the abstract on hypofractionation among prostate cancer patients has been accepted as a talk for the German Society for Radiooncology conference in June 2018.

REQUITE article: The Patient Perspective on Radiogenomics Testing for Breast Radiation Toxicity published in Clinical Oncology!

The article: "The Patient Perspective on Radiogenomics Testing for Breast Radiation Toxicity" from T.Rattay, P. Symonds, S.Shokuhi. C.J. Talbot and J.B.Schnur, has been published in Clinical Oncology, Volume 30, Issue 3, March 2018, Pages 151-157.

Poster at German Cancer Congress 2018!

The abstract "Quality of life and patient-reported early adverse effects in prostate cancer patients treated with radiotherapy in the multi-center observational REQUITE study" , Petra Seibold, et. al. was accepted as poster for the German Cancer Congress. The Deutscher Krebskongress (German Cancer Congress) is the largest and oldest congress covering cancer diagnostics and therapy in German-speaking countries. The 33rd German Cancer Congress took place from February 21 to 24, 2018, in Berlin. www.dkk2018.de.

Older news

Recruitment

Breast
2071
Lung
559
383*
Prostate
1809
* non-REQUITE patients included in our analyses

Events

ELCC 2018 European Lung Cancer Congress

The European Lung Cancer Congress is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, all working towards a shared goal: to advance science, disseminate education and improve the practice of lung cancer specialists worldwide.

Dirk de Ruysscher is one of the speakers in the educational session "Combined treatment stage IIIAre current NTCP models useful for predicting radiation-induced toxicity? 11.04.2018, 14:30-16:00 hour, Room A

For more information: website

Dates: 
Wednesday, 11 April, 2018 to Saturday, 14 April, 2018
Location: 
the Palexpo exhibition centre
30 Route François-Peyrot
1218 Geneva
Switzerland
CH

ESTRO 37: Innovation for Value and Access

ESTRO is a society focusing on interdisciplinarity and multidisciplinarity, giving radiation oncologists, medical physicists, radiobiologists, brachytherapists and radiation therapists (RTTs) the opportunity to engage with other oncology organisations with the collective aim of improving cancer treatment.

This conference will convey the theme ‘Innovation for Value and Access’. Click here for more information.

Catharine West, et. al.: REQUITE Big Data Resource for Validating Predictive Models and Biomarkers of Radiotherapy Toxicity, proffered papers, session about Biomarkers: to see the abstract click here

Dates: 
Friday, 20 April, 2018 to Tuesday, 24 April, 2018
Location: 
CCIB
Rambla Prim 1-17
08019 Barcelona
Spain
ES

Final REQUITE symposium

Annual REQUITE and Radiogenomics Consortium (RGC) meetings

Dates: 
Monday, 16 July, 2018 to Wednesday, 18 July, 2018
Location: 
Manchester
United Kingdom
GB

ESMO2018 Congress: Securing access to optimal cancer care

ESMO is and continues to be a leading force of high-quality oncology education, a platform for immense international visibility for scientific research, and a proud contributor to continuous improvements in patient care.

For more information: website

Dates: 
Friday, 19 October, 2018 to Tuesday, 23 October, 2018
Location: 
Messe Munich
Messegelände
81823 München
Germany
DE

ASTRO 2018

ASTRO’S Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year.

Abstract Submission Site Opens: December 13, 2017
Abstract Submission Site Closes: February 14, 2018

Dates: 
Sunday, 21 October, 2018 to Wednesday, 24 October, 2018
Location: 
Henry B. Gonzalez Convention Center
900 E Market St
TX 78205 San Antonio
United States
US